BETA

9 Amendments of Patrice TIROLIEN related to 2013/0243(COD)

Amendment 24 #
Proposal for a decision
Recital 4
(4) In 2009, independent experts adopted the report of the interim evaluation of EDCTP18. The opinion of the expert panel was that EDCTP1 provided a unique platform for a genuine dialogue with African scientists and it has started to bridge the gap between North and South in building research capacities and in providing learning and working opportunities for young African researchers. Following this report, there are fundamental issues to be taken into consideration for a second European and Developing Countries Clinical Trials Partnership Programme (hereinafter ''EDCTP2 Programme''): the current scope of EDCTP1 needs to be changed and extended; the integration of European national programmes should be further improved; collaboration with other major public and private funders, including the pharmaceutical industry,non-governmental organisations and foundations needs to be strengthened and extended; synergies with European external policy actions should be developed, in particular with EU development assistanceespecially with EU development assistance, including by earmarking part of the EU’s contribution to the Global Fund To Fight AIDS, Tuberculosis and Malaria for actions aimed at facilitating the transfer of EDCTP2 research results to the populations of developing countries, thereby strengthening their healthcare systems; co-funding rules should be clarified and simplified; monitoring tools need to be strengthened. __________________ 8 Van Velzen et al., Independent External Evaluation Report, December 2009.
2013/12/03
Committee: DEVE
Amendment 29 #
Proposal for a decision
Recital 28
(28) Since the objectives of this Decision, namely to contribute to the reduction of the social and economic burden of poverty- related diseases, neglected infectious diseases and diseases that chiefly affect children in developing countries and in particular in sub-Saharan Africa by accelerating the clinical development of effective, safe and affordable medical interventions for poverty-related diseases, cannot be sufficiently achieved by the Member States due to the lack of necessary critical mass to be achieved, both in human and financial terms, and can therefore, by reason of the scale of the action, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on the European Union. In accordance with the principle of proportionality, as set out in that Article, this Decision does not go beyond what is necessary for that purpose.
2013/12/03
Committee: DEVE
Amendment 34 #
Proposal for a decision
Annex 1 – point 1 – paragraph 1
EDCTP2 shall contribute to the reduction of the social and economic burden of poverty-related diseases, neglected infectious diseases and diseases that chiefly affect children in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe and affordable medical interventions for poverty-related diseases, in partnership with sub-Saharan Africa.
2013/12/03
Committee: DEVE
Amendment 39 #
Proposal for a decision
Annex 1 – point 2 – point a
a) an increased number of new or improved medical interventions for HIV/AIDS, tuberculosis, malaria and, other poverty- related diseases, andneglected infectious diseases and diseases that chiefly affect children; by the end of the programme to have delivered at least one new medical intervention; to have issued at least 30 guidelines for improved or extended use of existing medical interventions; and to have progressed the clinical development of at least 20 candidate medical intervention.
2013/12/03
Committee: DEVE
Amendment 40 #
Proposal for a decision
Annex 1 – point 2 – point d
d) extended international cooperation with other public and private funders, non-governmental organisations and foundations;
2013/12/03
Committee: DEVE
Amendment 42 #
Proposal for a decision
Annex 1 – point 3 – point a – paragraph 1
a) Support clinical trials on new or improved medical interventions for poverty-related diseases, neglected infectious diseases and diseases that chiefly affect children through partnerships between European and developing countries, in particular sub- Saharan Africa:
2013/12/03
Committee: DEVE
Amendment 49 #
Proposal for a decision
Annex 1 – point 3 – point e – paragraph 1
e) Establish cooperation and launch joint actions with other public and private funders., non-governmental organisations and foundations;
2013/12/03
Committee: DEVE
Amendment 50 #
Proposal for a decision
Annex 2 – point 1 – point a
a) promoting networking, coordination, alignment, cooperation and integration of national research programmes and activities on poverty-related infectious diseases, neglected infectious diseases and diseases that chiefly affect children at scientific, management and financial level;
2013/12/03
Committee: DEVE
Amendment 53 #
Proposal for a decision
Annex 2 – point 1 – point d
d) establishing cooperation and launching joint actions with other public and private funders, non-governmental organisations and foundations;
2013/12/03
Committee: DEVE